CLAL BIOTECHNOLOGY (Israel) Profile

<div class='logoBackup' style='background:#FF9E01;color: white;font-size:3em;;'>CLA</div>
Analyze Filter   Check how we calculate scores
Equity ratings for CLAL BIOTECHNOLOGY are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting October 21, 2019 and ending today January 19, 2020. Click here to learn more.
CLAL BIOTECHNOLOGY cannot be verified against its exchange. It appears that CLAL BIOTECHNOLOGY is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

CLAL BIOTECHNOLOGY Profile

Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It operates as a subsidiary of Clal Industries and Investments Ltd. CLAL BIOTECHNOLOGY operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.. The public information regarding CLAL BIOTECHNOLOGY's current market price is not available at this time.
NameCLAL BIOTECHNOLOGY
Chairman of the BoardAvraham FischerView All
Macroaxis Advice
Business AddressAzrieli Center
InstrumentIsrael Stock View All
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.cbi.co.il
Phone972 3 612 1616
CLAL BIOTECHNOLOGY (CBI) is traded on Tel Aviv Stock Exchange in Israel and employs 14 people. The company currently falls under 'Large-Cap' category with current market capitalization of 29.17 B. CLAL BIOTECHNOLOGY operates under Healthcare sector and is part of Biotechnology industry. The entity has 161.24 M outstanding shares. CLAL BIOTECH has accumulated about 94.71 M in cash with (69.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.59.
Check CLAL BIOTECHNOLOGY Probability Of Bankruptcy

CLAL BIOTECHNOLOGY Key Fundamentals

CLAL BIOTECHNOLOGY Against Markets

CLAL BIOTECHNOLOGY cannot be verified against its exchange. It appears that CLAL BIOTECHNOLOGY is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

Try Other Stock Suggestions

CLAL BIOTECHNOLOGY Corporate Directors

Sigalia Heifetz Director
Shmuel Rubinstein External Director
Tomer Babai Director
See also Trending Equities. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Company logos by clearbit